Last reviewed · How we verify
tirofiban intravenous bolus plus infusion
tirofiban intravenous bolus plus infusion is a Small molecule drug developed by Kosuyolu Heart Hospital. It is currently in Phase 3 development. Also known as: Aggrastat.
At a glance
| Generic name | tirofiban intravenous bolus plus infusion |
|---|---|
| Also known as | Aggrastat |
| Sponsor | Kosuyolu Heart Hospital |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion (PHASE4)
- HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) (PHASE3)
- Chronic Remote Ischemic Conditioning in Small Infarctions Associated with Stent-assisted Coiling of Unruptured Intracranial Aneurysms (NA)
- One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China (PHASE2)
- Tirofiban Plus Intravenous Thrombolysis in Acute Anterior Choroidal Infarction or Paramedian Pontine Infarction
- Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI. (PHASE4)
- European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial (PHASE3)
- BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tirofiban intravenous bolus plus infusion CI brief — competitive landscape report
- tirofiban intravenous bolus plus infusion updates RSS · CI watch RSS
- Kosuyolu Heart Hospital portfolio CI
Frequently asked questions about tirofiban intravenous bolus plus infusion
What is tirofiban intravenous bolus plus infusion?
tirofiban intravenous bolus plus infusion is a Small molecule drug developed by Kosuyolu Heart Hospital.
Who makes tirofiban intravenous bolus plus infusion?
tirofiban intravenous bolus plus infusion is developed by Kosuyolu Heart Hospital (see full Kosuyolu Heart Hospital pipeline at /company/kosuyolu-heart-hospital).
Is tirofiban intravenous bolus plus infusion also known as anything else?
tirofiban intravenous bolus plus infusion is also known as Aggrastat.
What development phase is tirofiban intravenous bolus plus infusion in?
tirofiban intravenous bolus plus infusion is in Phase 3.
Related
- Manufacturer: Kosuyolu Heart Hospital — full pipeline
- Also known as: Aggrastat
- Compare: tirofiban intravenous bolus plus infusion vs similar drugs
- Pricing: tirofiban intravenous bolus plus infusion cost, discount & access